Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 37Unknown 11Terminated 9Recruiting 5Withdrawn 4Active not recruiting 3Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

elbasvir-grazoprevir drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Hepatitis C × Clear all
NCT04190498 2022-05-24

ECHAPS

University Hospital, Grenoble

Withdrawn
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Sleep Apnea, Obstructive

NCT04546802 2020-09-14

HATCHeT

Bayside Health

Phase 3 Withdrawn
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT04395118 2020-07-02

STOP-HCC

University of Texas Southwestern Medical Center

Phase NA Withdrawn
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT01831037 2015-01-28

ROLFH

University of Arkansas

Withdrawn
Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis B, Chronic, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡